-+ 0.00%
-+ 0.00%
-+ 0.00%

Entera Bio FY 2024 GAAP EPS $(0.25), Sales $181.000K Beat $139.000K Estimate

Benzinga·03/28/2025 20:09:56
Listen to the news
Entera Bio (NASDAQ:ENTX) reported quarterly losses of $(0.25) per share. The company reported quarterly sales of $181.000 thousand which beat the analyst consensus estimate of $139.000 thousand by 30.22 percent.